However, recent studies have demonstrated that that HDACIs can induce the expression of interleukin 8 in ovarian cancer cells, which may promote the progression of ovarian cancer by promoting cell survival, proliferation, angiogenesis and metastasis [158]. This evidence concerns the gene CXCL8 and ovarian carcinoma.